Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane effects on inflammatory cytokines and HSP70 in women with preeclampsia
ChiCTR1800014571Phase 4Not yet recruiting
- Sponsor
- Guangdong Women and Children Hospital
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sevoflurane in preeclampsia (4 arms), sponsored by Guangdong Women and Children Hospital. Primary endpoints: Interleukin-6 and Heat shock protein 70. Planned start Jun 2018; status: not yet recruiting.
02
Drugs
sevoflurane
03
Conditions
preeclampsia
Beyond the preview
Go deeper on ChiCTR1800014571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014571.